Kenvue (NYSE:KVUE) vs. Synergy CHC (NASDAQ:SNYR) Head-To-Head Comparison

Synergy CHC (NASDAQ:SNYR) and Kenvue (NYSE:KVUE) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Institutional and Insider Ownership

97.6% of Kenvue shares are held by institutional investors. 56.6% of Synergy CHC shares are held by company insiders. Comparatively, 0.2% of Kenvue shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings for Synergy CHC and Kenvue, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	0	1	2	0	2.67
Kenvue	0	13	3	0	2.19

Synergy CHC currently has a consensus price target of $6.00, indicating a potential upside of 365.12%. Kenvue has a consensus price target of $19.58, indicating a potential upside of 13.61%. Given Synergy CHC’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Synergy CHC is more favorable than Kenvue.

Earnings & Valuation

This table compares Synergy CHC and Kenvue”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$34.83 million	0.42	$2.12 million	$0.29	4.45
Kenvue	$15.12 billion	2.18	$1.47 billion	$0.77	22.39

Kenvue has higher revenue and earnings than Synergy CHC. Synergy CHC is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Synergy CHC and Kenvue’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Synergy CHC	7.77%	-19.51%	14.25%
Kenvue	9.72%	19.72%	7.72%

Risk and Volatility

Synergy CHC has a beta of 3.63, meaning that its stock price is 263% more volatile than the S&P 500. Comparatively, Kenvue has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500.

Summary

Kenvue beats Synergy CHC on 9 of the 14 factors compared between the two stocks.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

About Kenvue

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.